Walgreens Boots Alliance (NASDAQ:WBA) Updates FY25 Earnings Guidance

Walgreens Boots Alliance (NASDAQ:WBA) issued an update on its FY25 earnings guidance on Friday morning. The company provided earnings per share guidance of $1.40-$1.80 for the period, compared to the consensus earnings per share estimate of $1.52. Walgreens Boots Alliance also updated its FY 2025 guidance to 1.400-1.800 EPS.

Walgreens Boots Alliance Price Performance

WBA stock opened at $9.22 on Friday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.37 and a current ratio of 0.68. The stock’s 50 day moving average price is $9.21 and its 200 day moving average price is $9.92. The firm has a market cap of $7.96 billion, a P/E ratio of -0.92, a PEG ratio of 1.36 and a beta of 0.64. Walgreens Boots Alliance has a 1 year low of $8.08 and a 1 year high of $25.63.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.13. The company had revenue of $39.50 billion for the quarter, compared to analysts’ expectations of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The firm’s revenue for the quarter was up 7.6% compared to the same quarter last year. During the same period last year, the company earned $0.66 EPS. On average, sell-side analysts expect that Walgreens Boots Alliance will post 1.53 earnings per share for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, December 12th. Shareholders of record on Monday, November 18th were issued a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 10.85%. The ex-dividend date of this dividend was Monday, November 18th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is -9.99%.

Analyst Ratings Changes

Several equities research analysts have commented on the company. Barclays upped their price target on Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research note on Wednesday, October 16th. Truist Financial cut their price target on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a report on Monday, October 7th. Morgan Stanley dropped their price objective on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a research report on Friday, October 11th. Evercore ISI lifted their target price on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the company an “in-line” rating in a report on Wednesday, October 16th. Finally, TD Cowen lowered their price target on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a report on Tuesday, October 22nd. Four analysts have rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company. According to data from MarketBeat, Walgreens Boots Alliance has a consensus rating of “Hold” and a consensus price target of $12.58.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.